A detailed history of Highlander Capital Management, LLC transactions in Histogen Inc. stock. As of the latest transaction made, Highlander Capital Management, LLC holds 17 shares of HSTO stock, worth $3. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 17 -0.0%
Holding current value
$3
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.39 - $0.88 $6 - $14
17 New
17 $0

Others Institutions Holding HSTO

# of Institutions
1
Shares Held
17
Call Options Held
0
Put Options Held
0

About Histogen Inc.


  • Ticker HSTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,497,450
  • Market Cap $524K
  • Description
  • Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media...
More about HSTO
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.